Filing Details
- Accession Number:
- 0001140361-10-000773
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-05 12:00:00
- Reporting Period:
- 2010-01-04
- Filing Date:
- 2010-01-05
- Accepted Time:
- 2010-01-05 18:44:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
319240 | Iris International Inc | IRIS | Laboratory Analytical Instruments (3826) | 942579751 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1408320 | Peter Donato | C/O Iris International, Inc. 9172 Eton Avenue Chatsworth CA 91311 | Corporate V.p. & C.f.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-04 | 50 | $12.04 | 11,565 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 75 | $12.07 | 11,490 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 14 | $12.08 | 11,476 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 203 | $12.08 | 11,273 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 48 | $12.09 | 11,225 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 28 | $12.10 | 11,197 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 34 | $12.11 | 11,163 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 82 | $12.11 | 11,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-01-04 | 50 | $12.50 | 11,031 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.